Full text
PDFPage 626
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bottermann P., Gyaram H., Wahl K., Ermler R., Lebender A. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique. Diabetes Care. 1982 Nov-Dec;5 (Suppl 2):43–52. doi: 10.2337/diacare.5.2.s43. [DOI] [PubMed] [Google Scholar]
- Ebihara A., Kondo K., Ohashi K., Kosaka K., Kuzuya T., Matsuda A. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects. Diabetes Care. 1983 Mar-Apr;6 (Suppl 1):17–22. [PubMed] [Google Scholar]
- From the GMSC: Discussions continue with DHSS on deputising services. Br Med J (Clin Res Ed) 1984 Feb 25;288(6417):655–656. [PMC free article] [PubMed] [Google Scholar]
- Heding L. G., Marshall M. O., Persson B., Dahlquist G., Thalme B., Lindgren F., Akerblom H. K., Rilva A., Knip M., Ludvigsson J. Immunogenicity of monocomponent human and porcine insulin in newly diagnosed type 1 (insulin-dependent) diabetic children. Diabetologia. 1984 Jul;27 (Suppl):96–98. doi: 10.1007/BF00275658. [DOI] [PubMed] [Google Scholar]
- Hildebrandt P., Berger A., Vølund A., Kühl C. The subcutaneous absorption of human and bovine ultralente insulin formulations. Diabet Med. 1985 Sep;2(5):355–359. doi: 10.1111/j.1464-5491.1985.tb00650.x. [DOI] [PubMed] [Google Scholar]
- Hildebrandt P., Birch K., Sestoft L., Vølund A. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins. Acta Med Scand. 1984;215(1):69–73. doi: 10.1111/j.0954-6820.1984.tb04971.x. [DOI] [PubMed] [Google Scholar]
- Owens D. R., Jones I. R., Birtwell A. J., Burge C. T., Luzio S., Davies C. J., Heyburn P., Heding L. G. Study of porcine and human isophane (NPH) insulins in normal subjects. Diabetologia. 1984 Apr;26(4):261–265. doi: 10.1007/BF00283647. [DOI] [PubMed] [Google Scholar]
- Owens D. R., Jones M. K., Hayes T. M., Heding L. G., Alberti K. G., Home P. D., Burrin J. M., Newcombe R. G. Human insulin: study of safety and efficacy in man. Br Med J (Clin Res Ed) 1981 Apr 18;282(6272):1264–1266. doi: 10.1136/bmj.282.6272.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pramming S., Lauritzen T., Thorsteinsson B., Johansen K., Binder C. Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) 1984 Feb;105(2):215–220. doi: 10.1530/acta.0.1050215. [DOI] [PubMed] [Google Scholar]
- Sonnenberg G. E., Chantelau E., Sundermann S., Hauff C., Berger M. Human and porcine regular insulins are equally effective in subcutaneous replacement therapy. Results of a double-blind crossover study in type I diabetic patients with continuous subcutaneous insulin infusion. Diabetes. 1982 Jul;31(7):600–602. doi: 10.2337/diab.31.7.600. [DOI] [PubMed] [Google Scholar]
- Williams G., Pickup J. C., Collins A. C., Keen H. Prostaglandin E1 accelerates subcutaneous insulin absorption in insulin-dependent diabetic patients. Diabet Med. 1984 Jul;1(2):109–113. doi: 10.1111/j.1464-5491.1984.tb01939.x. [DOI] [PubMed] [Google Scholar]